Targeted reduction of CCR4(+) cells is sufficient to suppress allergic airway inflammation

BACK GROUND: Bronchial asthma is characterized by allergic airway inflammation involving C-C chemokine receptor type 4 (CCR4)-positive Th2 cells. As such, we hypothesize that the disease can be alleviated by targeted-elimination of CCR4(+) cells. Thymus and activation-regulated chemokine (TARC)-PE38...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:Respir Investig
Hlavní autoři: Honjo, Akifumi, Ogawa, Hirohisa, Azuma, Masahiko, Tezuka, Toshifumi, Sone, Saburo, Biragyn, Arya, Nishioka, Yasuhiko
Médium: Artigo
Jazyk:Inglês
Vydáno: 2013
Témata:
Article
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC5846619/
https://ncbi.nlm.nih.gov/pubmed/24238232
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.resinv.2013.04.007
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky